Literature DB >> 22718113

Growth hormone/insulin-like growth factor-1 axis: a possible non-nutritional factor for growth retardation in children with cerebral palsy.

Moustafa A Hegazi1, Othman E Soliman, Bothina M Hasaneen, Mohammed El-Arman, Nawal Abd El-Galel, Basem S El-Deek.   

Abstract

OBJECTIVE: To assess growth hormone (GH)/insulin like growth factor-1 (IGF-1) axis as a possible non-nutritional factor for growth retardation in children with cerebral palsy (CP).
METHODS: A case-control study was conducted at a tertiary university hospital. Thirty children with CP (seven children with normal growth [CP-N] and 23 with retarded growth [CP-R]), 30 children with protein energy malnutrition (PEM), and 30 healthy children (REF group) underwent an assessment of growth parameters, serum IGF-1, basal GH, and peak GH after stimulation with insulin.
RESULTS: PEM patients had higher basal GH levels than CP-N, CP-R and REF groups (p = 0.026, p < 0.001, and p < 0.001 respectively). After insulin stimulation, CP-N, CP-R, and PEM patients had lower GH levels compared to the REF group (p = 0.04, p = 0.007, and p = 0.036 respectively). IGF-1 levels were lower in CP-R group compared to CP-N and REF groups (p = 0.037 and p < 0.001 respectively), and in PEM group compared to CP-N and REF groups (p < 0.001 and p < 0.001 respectively).
CONCLUSIONS: CP-R patients failed to demonstrate the same high basal GH response as PEM patients, and responded inadequately to the insulin stimulation test, but they had IGF-1 levels comparable to those of PEM patients. On the other hand, CP-N patients behaved as controls regarding their basal GH and IGF-1 levels, but failed to respond adequately to the insulin stimulation test. The PEM group presented high basal GH and low IGF-1 levels. These findings suggest that non-nutritional factors contribute to growth retardation in CP children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718113     DOI: 10.2223/jped.2197

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  3 in total

1.  Weight Status in the First 2 Years of Life and Neurodevelopmental Impairment in Extremely Low Gestational Age Newborns.

Authors:  Mandy B Belfort; Karl C K Kuban; T Michael O'Shea; Elizabeth N Allred; Richard A Ehrenkranz; Stephen C Engelke; Alan Leviton
Journal:  J Pediatr       Date:  2015-10-21       Impact factor: 4.406

2.  Associations of Circulating Insulin-Growth Factor-1 With Cognitive Functions and Quality of Life Domains in Ambulatory Young Adults With Cerebral Palsy: A Pilot Study.

Authors:  Ted Kheng Siang Ng; Patricia C Heyn; Alex Tagawa; Christina Coughlan; James J Carollo
Journal:  Front Neurol       Date:  2022-06-27       Impact factor: 4.086

3.  Growth in infants, children and adolescents with unilateral and bilateral cerebral palsy.

Authors:  Maria de Las Mercedes Ruiz Brunner; Eduardo Cuestas; Florian Heinen; Andreas Sebastian Schroeder
Journal:  Sci Rep       Date:  2022-02-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.